Agilent Technologies and Transcriptic Collaborate to Automate Discovery Biology

Agilent Technologies Inc. (NYSE: A) and Transcriptic Inc. have agreed to partner their technologies to provide a solution for convenient, broad scale synthetic and discovery biology research.

Agilent continues its strong program of fostering innovation using the Agilent portfolio by collaborating with rising companies such as Transcriptic to develop novel synthetic biology solutions. Transcriptic’s automated discovery biology platform enables scalable life science research through a convenient and simple web interface. Biologists who use the platform can control their science and generate data remotely via the cloud.

Please to read the entire article.

You must be logged in to post a comment Login